<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03744624</url>
  </required_header>
  <id_info>
    <org_study_id>122.6120.81.2017</org_study_id>
    <secondary_id>0054/DIA/2018/47</secondary_id>
    <nct_id>NCT03744624</nct_id>
  </id_info>
  <brief_title>Application of 3D Printing in Laparoscopic Surgery of Liver Tumors</brief_title>
  <official_title>Application of 3D Printing in Laparoscopic Surgery of Liver Tumors</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Jagiellonian University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Jagiellonian University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To explore the utility of personalized 3D printed liver models in planning and navigating
      laparoscopic resections.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Project goal is to evaluate utility of personalized 3D printed models in preoperative
      planning and performing laparoscopic liver resections. Models will be developed with unique,
      low-cost approach. Project will consist of three overlapping modules/stages evaluating:

        1. Accuracy of 3D printed liver models compared to computed tomography and standard surface
           or volume rendering

        2. Whether 3D printed utilized in planning surgery affects the decision making regarding
           the surgical plan

        3. Whether 3D printed models utilized in planning and navigating laparoscopic resections
           affect perioperative outcomes

      Methodology of developing 3D models is described elsewhere. Printed models will be delivered
      to surgical team at least 5 days prior to the resection. Surgery will be performed in both
      arms according to the department's procedures and surgical oncology guidelines.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 28, 2017</start_date>
  <completion_date type="Anticipated">December 2022</completion_date>
  <primary_completion_date type="Anticipated">December 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of changes in surgery plan</measure>
    <time_frame>intraoperative</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Blood loss</measure>
    <time_frame>intraoperative</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Operative time</measure>
    <time_frame>intraoperative</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Complications</measure>
    <time_frame>intraoperative and until discharge, an average of 7 days</time_frame>
    <description>Number of both total and severe (Clavien-Dindo&gt;=3) complications</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of stay</measure>
    <time_frame>until patient discharge, an average of 7 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Conversion rate</measure>
    <time_frame>intraoperative</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Readmissions</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mortality</measure>
    <time_frame>90 days</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">85</enrollment>
  <condition>Liver Cancer</condition>
  <condition>Hepatocellular Carcinoma</condition>
  <condition>Liver Metastases</condition>
  <arm_group>
    <arm_group_label>With 3D Model</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients in this arm will undergo laparoscopic liver resection with prior planning utilizing both 3D printed model and computed tomography (or/and magnetic resonance imaging)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Without 3D Model</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients in this arm will undergo laparoscopic liver resection with prior planning utilizing only standard medical imaging computed tomography (or/and magnetic resonance imaging) without development of 3D printed model</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Laparoscopic liver resection</intervention_name>
    <description>Laparoscopic liver resection for oncological purposes</description>
    <arm_group_label>With 3D Model</arm_group_label>
    <arm_group_label>Without 3D Model</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>3D printing model</intervention_name>
    <description>Use of 3D printed liver model in decision-making: preoperative planning and intraoperative guidance.</description>
    <arm_group_label>With 3D Model</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age over 18

          -  Patient qualified to undergo liver tumor resection (either primary of metastatic; both
             benign and malignant lesions)

          -  Quality of imaging (CT or MRI or PET (positron emission tomography)/CT) satisfactory
             to develop 3D models

          -  Laparoscopic approach

          -  Informed consent

        Exclusion Criteria:

          -  Open approach

          -  Technical limitations to model development

          -  No informed consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jan S Witowski</last_name>
    <phone>+48531646868</phone>
    <email>jwitos@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>2nd Department of General Surgery Jagiellonian Univeristy Medical College</name>
      <address>
        <city>Kraków</city>
        <state>Małopolskie</state>
        <zip>31-501</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jan S Witowski</last_name>
      <phone>+48531646868</phone>
      <email>jwitos@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Poland</country>
  </location_countries>
  <reference>
    <citation>Witowski JS, Pędziwiatr M, Major P, Budzyński A. Cost-effective, personalized, 3D-printed liver model for preoperative planning before laparoscopic liver hemihepatectomy for colorectal cancer metastases. Int J Comput Assist Radiol Surg. 2017 Dec;12(12):2047-2054. doi: 10.1007/s11548-017-1527-3. Epub 2017 Jan 31.</citation>
    <PMID>28144830</PMID>
  </reference>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>November 13, 2018</study_first_submitted>
  <study_first_submitted_qc>November 14, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">November 16, 2018</study_first_posted>
  <last_update_submitted>August 11, 2019</last_update_submitted>
  <last_update_submitted_qc>August 11, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 13, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Jagiellonian University</investigator_affiliation>
    <investigator_full_name>Jan Witowski</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>3D printing</keyword>
  <keyword>Liver cancer</keyword>
  <keyword>Laparoscopic surgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carcinoma, Hepatocellular</mesh_term>
    <mesh_term>Liver Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

